Anemia (Renal) Secondary to Chronic Kidney Disease (CKD)

Yes. Under 38 CFR § 3.310(a), any disability proximately caused or chronically worsened by a service-connected condition is itself service-connected. Anemia (Renal) is a documented secondary pairing for Chronic Kidney Disease (CKD) with strong medical evidence. A nexus letter from a qualified physician linking the two conditions is the most reliable way to establish this connection.

The gold standard is a private nexus opinion stating — to at least a 50% probability ("at least as likely as not") — that the secondary condition was caused or aggravated by the primary service-connected condition. Peer-reviewed medical literature supporting the physiological mechanism strengthens the nexus. Treatment records documenting the onset or worsening of the secondary condition in temporal relation to the primary are supporting evidence.

The VA rates Anemia (Renal) separately under its own 38 CFR Part 4 diagnostic code, then combines it with Chronic Kidney Disease (CKD) and all other service-connected ratings using the combined ratings formula under § 4.25. The formula applies the whole-person concept: a 50% combined existing rating plus a new 30% rating yields 65% (rounded to 70%), not 80%.

38 CFR § 3.310(a) states: "Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected." The aggravation variant under § 3.310(b) applies where the primary condition permanently worsens a pre-existing disability beyond its natural progression. Both standards require a showing of nexus — a medical or scientific link between the primary condition and the secondary.

The medical evidence supporting Anemia (Renal) as secondary to Chronic Kidney Disease (CKD) is rated strong. The kidneys produce 90% of circulating erythropoietin (EPO), the glycoprotein hormone that stimulates red blood cell production in the bone marrow. As CKD progresses and functional renal parenchyma is lost, EPO production declines proportionally, resulting in normocytic normochromic anemia of chronic kidney disease. This EPO-deficient anemia typically becomes clinically significant at GFR <45 mL/min (CKD Stage 3b) and is nearly universal by GFR <15 mL/min (CKD Stage 5). Additionally, uremic toxins suppress erythropoiesis directly, shorten red blood cell lifespan from the normal 120 days to 60-90 days, and impair iron absorption and utilization. CKD-related anemia produces fatigue, exercise intolerance, cognitive impairment, and cardiovascular strain from compensatory increased cardiac output.

The VA will not solicit nexus evidence on your behalf for secondary claims. In practice, a written nexus opinion from a private physician or independent medical examiner is essential — the VA's Compensation & Pension (C&P) examiner is not required to produce a favorable nexus opinion, and the VA has discretion to weigh competing opinions. Submitting a private nexus letter at the time of filing is the most reliable strategy.